These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31931126)

  • 1. Selective Use of Anticoagulation or Dual Antiplatelet Therapy for Patients with Extra-anatomic Bypasses.
    Teveris V; Columbo J; Bartline P; Goodney P; Stone D; Suckow B
    Ann Vasc Surg; 2020 Jul; 66():272-281.e1. PubMed ID: 31931126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dual antiplatelet therapy on graft patency after lower extremity bypass.
    Belkin N; Stoecker JB; Jackson BM; Damrauer SM; Glaser J; Kalapatapu V; Golden MA; Wang GJ
    J Vasc Surg; 2021 Mar; 73(3):930-939. PubMed ID: 32777321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of postoperative antithrombotic therapy on lower extremity outcomes after infrapopliteal bypass for chronic limb-threatening ischemia.
    Marcaccio CL; Patel PB; Wang S; Rastogi V; Moreira CC; Siracuse JJ; Schermerhorn ML; Stangenberg L
    J Vasc Surg; 2022 May; 75(5):1696-1706.e4. PubMed ID: 35074410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of precuffed expanded polytetrafluorothylene and heparin-bonded polytetrafluorothylene graft in crural bypass.
    Bellosta R; Natalini G; Luzzani L; Carugati C; Sarcina A
    Ann Vasc Surg; 2013 Feb; 27(2):218-24. PubMed ID: 23092735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
    Savarese G; Reiner MF; Uijl A; D'Amario D; Agewall S; Atar D; Baumgartner I; Borghi C; De Carlo M; Drexel H; Kaski JC; Kjeldsen KP; Kucher N; Lund LH; Niessner A; Semb AG; Schmidt TA; Sulzgruber P; Tamargo J; Vitale C; Wassmann S; Aboyans V; Lewis BS
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):86-93. PubMed ID: 31392312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.
    Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G
    J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair.
    Fan EY; Schanzer A; Beck AW; Eagleton MJ; Farber MA; Gasper WJ; Lee WA; Oderich GS; Parodi FE; Schneider DB; Sweet MP; Timaran CH; Simons JP;
    J Vasc Surg; 2024 Oct; 80(4):968-978.e3. PubMed ID: 38796031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia.
    Ramanan B; Jeon-Slaughter H; Chen X; Kashyap VS; Kirkwood ML; Timaran CH; Modrall JG; Tsai S
    J Vasc Surg; 2021 Oct; 74(4):1327-1334. PubMed ID: 34023428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia.
    Suckow BD; Kraiss LW; Stone DH; Schanzer A; Bertges DJ; Baril DT; Cronenwett JL; Goodney PP;
    Ann Vasc Surg; 2013 Nov; 27(8):1134-45. PubMed ID: 24011814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of anticoagulation on midterm infrainguinal bypass graft patency.
    Liang NL; Baril DT; Avgerinos ED; Leers SA; Makaroun MS; Chaer RA
    J Vasc Surg; 2017 Aug; 66(2):499-505.e2. PubMed ID: 28400219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in Antithrombotic Therapy after Infrainguinal Lower Extremity Bypass.
    Brahmandam A; Lee M; Bellamkonda K; Provance JB; Sumpio B; Ochoa Chaar CI; Smolderen KG; Mena-Hurtado C; Guzman RJ
    Ann Vasc Surg; 2023 Jan; 88():51-62. PubMed ID: 36245106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure.
    Brumberg RS; Back MR; Armstrong PA; Cuthbertson D; Shames ML; Johnson BL; Bandyk DF
    J Vasc Surg; 2007 Dec; 46(6):1160-6. PubMed ID: 17920227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-based outcomes of lower extremity bypass surgery in hemodialysis patients.
    Arhuidese I; Kernodle A; Nejim B; Locham S; Hicks C; Malas MB
    J Vasc Surg; 2018 Jul; 68(1):153-160. PubMed ID: 29276108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics.
    Dorigo W; Pulli R; Castelli P; Dorrucci V; Ferilli F; De Blasis G; Monaca V; Vecchiati E; Pratesi C;
    J Vasc Surg; 2011 Nov; 54(5):1332-8. PubMed ID: 21840151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of infrainguinal revascularization with bypass surgery using a heparin-bonded graft for disabling intermittent claudication due to femoropopliteal occlusive disease.
    Piffaretti G; Dorigo W; Ottavi P; Pulli R; Castelli P; Pratesi C;
    J Vasc Surg; 2019 Jul; 70(1):166-174.e1. PubMed ID: 31113719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of direct oral anticoagulants after lower extremity arterial procedures.
    Aurshina A; Kibrik P; Eisenberg J; Alsheekh A; Hingorani A; Marks N; Ascher E
    Vascular; 2018 Apr; 26(2):189-193. PubMed ID: 28820359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization.
    Kim TI; DeWan A; Murray M; Wang H; Mani A; Mena-Hurtado C; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2024 Aug; 105():150-157. PubMed ID: 38593922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Antithrombotic Therapy versus Anticoagulant Monotherapy for Major Adverse Limb Events in Patients with Concomitant Lower Extremity Arterial Disease and Atrial Fibrillation: A Propensity Score Weighted Analysis.
    Lin DS; Wu HP; Chung WJ; Hsueh SK; Hsu PC; Lee JK; Chen CC; Huang HL
    Eur J Vasc Endovasc Surg; 2024 Oct; 68(4):498-507. PubMed ID: 38754724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.